Lumacaftor/Ivacaftor
Drug timelines are a Plus or Pro feature.
11 regulatory and trial events tracked for Lumacaftor/Ivacaftor, covering 2015-09-01 to 2024-09-19. Get the full timeline:
Most recent: Clinical Trial Update: Long-term Safety of Lumacaftor/Ivacaftor in Participants With Cystic Fibrosis Who Are Homozygous for F508del and 12 to <24 Months of Age at Treatment Initiation [Phase 3]